Protein tyrosine phosphatase epsilon and Neu-induced mammary tumorigenesis

Cancer and Metastasis Reviews

Volumn 27, Issue 2, 2008, Pages 193-203

  Berman Golan, Dalia ^a   Granot Attas, Shira ^a   Elson, Ari ^a  

^a WEIZMANN INSTITUTE OF SCIENCE   (Israel)

Author keywords

Breast cancer; ErbbB2; HER2; Neu; Src; Tyrosine phosphatase

Indexed keywords

NEU DIFFERENTIATION FACTOR; PROTEIN TYROSINE KINASE; PROTEIN TYROSINE PHOSPHATASE EPSILON;

BREAST CANCER; CARBOXY TERMINAL SEQUENCE; CARCINOGENESIS; CELL ISOLATION; CELL PROLIFERATION; EXPERIMENTAL MODEL; HUMAN; HYPERPLASIA; IN VIVO STUDY; MAMMARY GLAND; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REVIEW; TRANSGENE; TUMOR CELL;

ANIMALS; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; RECEPTOR, ERBB-2; RECEPTOR-LIKE PROTEIN TYROSINE PHOSPHATASES, CLASS 4; SIGNAL TRANSDUCTION;

EID: 43049103406     PISSN: 01677659     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10555-008-9124-0     Document Type: Review

References (106)

1. Hunter, T. (2000). Signaling-2000 and beyond. Cell, 100, 113-127.
2. Schlessinger, J. (2000). Cell signaling by receptor tyrosine kinases. Cell, 103, 211-225.
3. Manning, G., Whyte, D. B., Martinez, R., Hunter, T., & Sudarsanam, S. (2002). The protein kinase complement of the human genome. Science, 298, 1912-1934.
4. Alonso, A., Sasin, J., Bottini, N., Friedberg, I., Osterman, A., Godzik, A., et al. (2004). Protein tyrosine phosphatases in the human genome. Cell, 117, 699-711.
5. Thomas, S. M., & Brugge, J. S. (1997). Cellular functions regulated by Src family kinases. Annual Review of Cell and Developmental Biology, 13, 513-609.
6. Wu, J., & Luo, H. (2005). Recent advances on T-cell regulation by receptor tyrosine kinases. Current Opinion in Hematology, 12, 292-297.
7. Denu, J. M., & Dixon, J. E. (1998). Protein tyrosine phosphatases: mechanisms of catalysis and regulation. Current Opinion in Chemical Biology, 2, 633-641.
8. Barford, D., Das, A. K., & Egloff, M. P. (1998). The structure and mechanism of protein phosphatases: Insights into catalysis and regulation. Annual Review of Biophysics and Biomolecular Structure, 27, 133-164.
9. Wang, W. Q., Sun, J. P., & Zhang, Z. Y. (2003). An overview of the protein tyrosine phosphatase superfamily. Current Topics in Medicinal Chemistry, 3, 739-748.
10. Andersen, J. N., Jansen, P. G., Echwald, S. M., Mortensen, O. H., Fukada, T., Del Vecchio, R., et al. (2004). A genomic perspective on protein tyrosine phosphatases: gene structure, pseudogenes, and genetic disease linkage. FASEB Journal, 18, 8-30.
11. Andersen, J. N., Mortensen, O. H., Peters, G. H., Drake, P. G., Iversen, L. F., Olsen, O. H., et al. (2001). Structural and evolutionary relationships among protein tyrosine phosphatase domains. Molecular and Cellular Biology, 21, 7117-7136.
12. Wang, Y., & Pallen, C. J. (1991). The receptor-like protein tyrosine phosphatase HPTP alpha has two active catalytic domains with distinct substrate specificities. EMBO Journal, 10, 3231-3237.
13. Wu, L., Buist, A., den Hertog, J., & Zhang, Z. Y. (1997). Comparative kinetic analysis and substrate specificity of the tandem catalytic domains of the receptor-like protein-tyrosine phosphatase alpha. Journal of Biological Chemistry, 272, 6994-7002.
14. den Hertog, J., Blanchetot, C., Buist, A., Overvoorde, J., van der Sar, A., & Tertoolen, L. G. (1999). Receptor protein-tyrosine phosphatase signalling in development. International Journal of Developmental Biology, 43, 723-733.
15. Jiang, G., den Hertog, J., & Hunter, T. (2000). Receptor-like protein tyrosine phosphatase alpha homodimerizes on the cell surface. Molecular and Cellular Biology, 20, 5917-5929.
16. Jiang, G., den Hertog, J., Su, J., Noel, J., Sap, J., & Hunter, T. (1999). Dimerization inhibits the activity of receptor-like protein-tyrosine phosphatase-alpha. Nature, 401, 606-610.
17. Meng, K., Rodriguez-Pena, A., Dimitrov, T., Chen, W., Yamin, M., Noda, M., et al. (2000). Pleiotrophin signals increased tyrosine phosphorylation of beta beta-catenin through inactivation of the intrinsic catalytic activity of the receptor-type protein tyrosine phosphatase beta/zeta. Proceedings of the National Academy of Sciences of the United States of America, 97, 2603-2608.
18. Xu, Z., & Weiss, A. (2002). Negative regulation of CD45 by differential homodimerization of the alternatively spliced isoforms. Nature Immunology, 3, 764-771.
19. Stoker, A. (2005). Methods for identifying extracellular ligands of RPTPs. Methods, 35, 80-89.
20. Sallee, J. L., Wittchen, E. S., & Burridge, K. (2006). Regulation of cell adhesion by protein-tyrosine phosphatases: II. Cell-cell adhesion. Journal of Biological Chemistry, 281, 16189-16192.
21. Frangioni, J. V., Oda, A., Smith, M., Salzman, E. W., & Neel, B. G. (1993). Calpain-catalyzed cleavage and subcellular relocation of protein phosphotyrosine phosphatase 1B (PTP-1B) in human platelets. EMBO Journal, 12, 4843-4856.
22. Gil-Henn, H., Volohonsky, G., & Elson, A. (2001). Regulation of protein-tyrosine phosphatases alpha and epsilon by calpain-mediated proteolytic cleavage. Journal of Biological Chemistry, 276, 31772-31779.
23. Chagnon, M. J., Uetani, N., & Tremblay, M. L. (2004). Functional significance of the LAR receptor protein tyrosine phosphatase family in development and diseases. Biochemistry and Cell Biology, 82, 664-675.
24. van der Wijk, T., Blanchetot, C., & den Hertog, J. (2005). Regulation of receptor protein-tyrosine phosphatase dimerization. Methods, 35, 73-79.
25. Stoker, A. W. (2005). Protein tyrosine phosphatases and signalling. Journal of Endocrinology, 185, 19-33.
26. Toledano-Katchalski, H., Tiran, Z., Sines, T., Shani, G., Granot-Attas, S., den Hertog, J., et al. (2003). Dimerization in vivo and inhibition of the nonreceptor form of protein tyrosine phosphatase epsilon. Molecular and Cellular Biology, 23, 5460-5471.
27. Tonks, N. K. (2005). Redox redux: revisiting PTPs and the control of cell signaling. Cell, 121, 667-670.
28. den Hertog, J., Groen, A., & van der Wijk, T. (2005). Redox regulation of protein-tyrosine phosphatases. Archives of Biochemistry and Biophysics, 434, 11-15.
29. Meng, T. C., Fukada, T., & Tonks, N. K. (2002). Reversible oxidation and inactivation of protein tyrosine phosphatases in vivo. Molecular Cell, 9, 387-399.
30. Zheng, X. M., Resnick, R. J., & Shalloway, D. (2000). A phosphotyrosine displacement mechanism for activation of Src by PTPalpha. EMBO Journal, 19, 964-978.
31. Zheng, X. M., Resnick, R. J., & Shalloway, D. (2002). Mitotic activation of protein-tyrosine phosphatase alpha and regulation of its Src-mediated transforming activity by its sites of protein kinase C phosphorylation. Journal of Biological Chemistry, 277, 21922-21929.
32. Chen, M., Chen, S. C., & Pallen, C. J. (2006). Integrin-induced tyrosine phosphorylation of protein-tyrosine phosphatase-alpha is required for cytoskeletal reorganization and cell migration. Journal of Biological Chemistry, 281, 11972-11980.
33. Bence, K. K., Delibegovic, M., Xue, B., Gorgun, C. Z., Hotamisligil, G. S., Neel, B. G., et al. (2006). Neuronal PTP1B regulates body weight, adiposity and leptin action. Nature Medicine, 12, 917-924.
34. Haj, F. G., Zabolotny, J. M., Kim, Y. B., Kahn, B. B., & Neel, B. G. (2005). Liver-specific protein-tyrosine phosphatase 1B (PTP1B) re-expression alters glucose homeostasis of PTP1B-/-mice. Journal of Biological Chemistry, 280, 15038-15046.
35. Klaman, L. D., Boss, O., Peroni, O. D., Kim, J. K., Martino, J. L., Zabolotny, J. M., et al. (2000). Increased energy expenditure, decreased adiposity, and tissue-specific insulin sensitivity in protein-tyrosine phosphatase 1B-deficient mice. Molecular and Cellular Biology, 20, 5479-5489.
36. Zabolotny, J. M., Bence-Hanulec, K. K., Stricker-Krongrad, A., Haj, F., Wang, Y., Minokoshi, Y., et al. (2002). PTP1B regulates leptin signal transduction in vivo. Developmental Cell, 2, 489-495.
37. Cheng, A., Uetani, N., Simoncic, P. D., Chaubey, V. P., Lee-Loy, A., McGlade, C. J., et al. (2002). Attenuation of leptin action and regulation of obesity by protein tyrosine phosphatase 1B. Developmental Cell, 2, 497-503.
38. Elchebly, M., Payette, P., Michaliszyn, E., Cromlish, W., Collins, S., Loy, A. L., et al. (1999). Increased insulin sensitivity and obesity resistance in mice lacking the protein tyrosine phosphatase-1B gene. Science, 283, 1544-1548.
39. Ostman, A., Hellberg, C., & Bohmer, F. D. (2006). Protein-tyrosine phosphatases and cancer. Nature Reviews. Cancer, 6, 307-320.
40. Bourdeau, A., Dube, N., & Tremblay, M. L. (2005). Cytoplasmic protein tyrosine phosphatases, regulation and function: The roles of PTP1B and TC-PTP. Current Opinion in Cell Biology, 17, 203-209.
41. Schiller, K. R., & Mauro, L. J. (2005). Tyrosine phosphatases as regulators of skeletal development and metabolism. Journal of Cellular Biochemistry, 96, 262-277.
42. Mustelin, T., Vang, T., & Bottini, N. (2005). Protein tyrosine phosphatases and the immune response. Nature Reviews. Immunology, 5, 43-57.
43. Larsen, M., Tremblay, M. L., & Yamada, K. M. (2003). Phosphatases in cell-matrix adhesion and migration. Nature Reviews. Molecular Cell Biology, 4, 700-711.
44. Burridge, K., Sastry, S. K., & Sallee, J. L. (2006). Regulation of cell adhesion by protein-tyrosine phosphatases. I. Cell-matrix adhesion. Journal of Biological Chemistry, 281, 15593-15596.
45. Angers-Loustau, A., Cote, J. F., & Tremblay, M. L. (1999). Roles of protein tyrosine phosphatases in cell migration and adhesion. Biochemistry and Cell Biology, 77, 493-505.
46. Berman-Golan, D., & Elson, A. (2007). Neu-mediated phosphorylation of protein tyrosine phosphatase epsilon is critical for activation of Src in mammary tumor cells. Oncogene, 26, 7028-7037.
47. Tautz, L., Pellecchia, M., & Mustelin, T. (2006). Targeting the PTPome in human disease. Expert Opinion on Therapeutic Targets, 10, 157-177.
48. Taylor, S. D., & Hill, B. (2004). Recent advances in protein tyrosine phosphatase 1B inhibitors. Expert Opinion on Investigational Drugs, 13, 199-214.
49. Elson, A., & Leder, P. (1995). Protein-tyrosine phosphatase epsilon. An isoform specifically expressed in mouse mammary tumors initiated by v-Ha-ras OR neu. Journal of Biological Chemistry, 270, 26116-26122.
50. Krueger, N. X., Streuli, M., & Saito, H. (1990). Structural diversity and evolution of human receptor-like protein tyrosine phosphatases. EMBO Journal, 9, 3241-3252.
51. Elson, A., & Leder, P. (1995). Identification of a cytoplasmic, phorbol ester-inducible isoform of protein tyrosine phosphatase epsilon. Proceedings of the National Academy of Sciences of the United States of America, 92, 12235-12239.
52. Tanuma, N., Nakamura, K., & Kikuchi, K. (1999). Distinct promoters control transmembrane and cytosolic protein tyrosine phosphatase epsilon expression during macrophage differentiation. European Journal of Biochemistry, 259, 46-54.
53. Nakamura, K., Mizuno, Y., & Kikuchi, K. (1996). Molecular cloning of a novel cytoplasmic protein tyrosine phosphatase PTP epsilon. Biochemical and Biophysical Research Communications, 218, 726-732.
54. Gil-Henn, H., Volohonsky, G., Toledano-Katchalski, H., Gandre, S., & Elson, A. (2000). Generation of novel cytoplasmic forms of protein tyrosine phosphatase epsilon by proteolytic processing and translational control. Oncogene, 19, 4375-4384.
55. Wabakken, T., Hauge, H., Funderud, S., & Aasheim, H. C. (2002). Characterization, expression and functional aspects of a novel protein tyrosine phosphatase epsilon isoform. Scandinavian Journal of Immunology, 56, 276-285.
56. Sines, T., Granot-Attas, S., Weisman-Welcher, S., & Elson, A. (2007). Association of tyrosine phosphatase epsilon with microtubules inhibits phosphatase activity and is regulated by the epidermal growth factor receptor. Molecular and Cellular Biology, 27, 7102-7112.
57. Tiran, Z., Peretz, A., Shinder, V., Sap, J., Attali, B., & Elson, A. (2006). PTPs Epsilon and Alpha perform specific and overlapping functions in regulation of voltage-gated potassium channels and axon myelination. Molecular Biology of the Cell, 17(10), 4330-4342.
58. Peretz, A., Gil-Henn, H., Sobko, A., Shinder, V., Attali, B., & Elson, A. (2000). Hypomyelination and increased activity of voltage-gated K(+) channels in mice lacking protein tyrosine phosphatase epsilon. EMBO Journal, 19, 4036-4045.
59. Muja, N., Lovas, G., Romm, E., Machleder, D., Ranjan, M., Gallo, V., et al. (2004). Expression of a catalytically inactive transmembrane protein tyrosine phosphatase epsilon (tm-PTP epsilon) delays optic nerve myelination. Glia, 48, 278-297.
60. Chiusaroli, R., Knobler, H., Luxenburg, C., Sanjay, A., Granot-Attas, S., Tiran, Z., et al. (2004). Tyrosine phosphatase epsilon is a positive regulator of osteoclast function in vitro and in vivo. Molecular Biology of the Cell, 15, 234-244.
61. Kollet, O., Dar, A., Shivtiel, S., Kalinkovich, A., Lapid, K., Sztainberg, Y., et al. (2006). Osteoclasts degrade endosteal components and promote mobilization of hematopoietic progenitor cells. Nature Medicine, 12, 657-664.
62. Wabakken, T., Hauge, H., Finne, E. F., Wiedlocha, A., & Aasheim, H. (2002). Expression of human protein tyrosine phosphatase epsilon in leucocytes: A potential ERK pathway-regulating phosphatase. Scandinavian Journal of Immunology, 56, 195-203.
63. Toledano-Katchalski, H., Kraut, J., Sines, T., Granot-Attas, S., Shohat, G., Gil-Henn, H., et al. (2003). Protein tyrosine phosphatase epsilon inhibits signaling by mitogen-activated protein kinases. Molecular Cancer Research, 1, 541-550.
64. Tanuma, N., Shima, H., Shimada, S., & Kikuchi, K. (2003). Reduced tumorigenicity of murine leukemia cells expressing protein-tyrosine phosphatase, PTPepsilon C. Oncogene, 22, 1758-1762.
65. Tanuma, N., Shima, H., Nakamura, K., & Kikuchi, K. (2001). Protein tyrosine phosphatase epsilonC selectively inhibits interleukin-6- and interleukin- 10-induced JAK-STAT signaling. Blood, 98, 3030-3034.
66. Tanuma, N., Nakamura, K., Shima, H., & Kikuchi, K. (2000). Protein-tyrosine phosphatase PTPepsilon C inhibits Jak-STAT signaling and differentiation induced by interleukin-6 and leukemia inhibitory factor in M1 leukemia cells. Journal of Biological Chemistry, 275, 28216-28221.
67. Thompson, L. J., Jiang, J., Madamanchi, N., Runge, M. S., & Patterson, C. (2001). PTP-epsilon, a tyrosine phosphatase expressed in endothelium, negatively regulates endothelial cell proliferation. American Journal of Physiology. Heart and Circulatory Physiology, 281, H396-H403.
68. Andersen, J. N., Elson, A., Lammers, R., Romer, J., Clausen, J. T., Moller, K. B., et al. (2001). Comparative study of protein tyrosine phosphatase-epsilon isoforms: membrane localization confers specificity in cellular signalling. Biochemical Journal, 354, 581-590.
69. Moller, N. P., Moller, K. B., Lammers, R., Kharitonenkov, A., Hoppe, E., Wiberg, F. C., et al. (1995). Selective down-regulation of the insulin receptor signal by protein-tyrosine phosphatases alpha and epsilon. Journal of Biological Chemistry, 270, 23126-23131.
70. Nakagawa, Y., Aoki, N., Aoyama, K., Shimizu, H., Shimano, H., Yamada, N., et al. (2005). Receptor-type protein tyrosine phosphatase epsilon (PTPepsilonM) is a negative regulator of insulin signaling in primary hepatocytes and liver. Zoological Science, 22, 169-175.
71. Sully, V., Pownall, S., Vincan, E., Bassal, S., Borowski, A. H., Hart, P. H., et al. (2001). Functional abnormalities in protein tyrosine phosphatase epsilon-deficient macrophages. Biochemical and Biophysical Research Communications, 286, 184-188.
72. Cardiff, R. D., Sinn, E., Muller, W., & Leder, P. (1991). Transgenic oncogene mice. Tumor phenotype predicts genotype. American Journal of Pathology, 139, 495-501.
73. Elson, A. (1999). Protein tyrosine phosphatase epsilon increases the risk of mammary hyperplasia and mammary tumors in transgenic mice. Oncogene, 18, 7535-7542.
74. Muller, W. J., Sinn, E., Pattengale, P. K., Wallace, R., & Leder, P. (1988). Single-step induction of mammary adenocarcinoma in transgenic mice bearing the activated c-neu oncogene. Cell, 54, 105-115.
75. Gil-Henn, H., & Elson, A. (2003). Tyrosine phosphatase-epsilon activates Src and supports the transformed phenotype of Neu-induced mammary tumor cells. Journal of Biological Chemistry, 278, 15579-15586.
76. Flint, A. J., Tiganis, T., Barford, D., & Tonks, N. K. (1997). Development of "substrate-trapping" mutants to identify physiological substrates of protein tyrosine phosphatases. Proceedings of the National Academy of Sciences of the United States of America, 94, 1680-1685.
77. Blanchetot, C., Chagnon, M., Dube, N., Halle, M., & Tremblay, M. L. (2005). Substrate-trapping techniques in the identification of cellular PTP targets. Methods, 35, 44-53.
78. Granot-Attas, S., & Elson, A. (2004). Protein tyrosine phosphatase epsilon activates Yes and Fyn in Neu-induced mammary tumor cells. Experimental Cell Research, 294, 236-243.
79. Zheng, X. M., Wang, Y., & Pallen, C. J. (1992). Cell transformation and activation of pp60c-src by overexpression of a protein tyrosine phosphatase. Nature, 359, 336-339.
80. Su, J., Muranjan, M., & Sap, J. (1999). Receptor protein tyrosine phosphatase alpha activates Src-family kinases and controls integrin-mediated responses in fibroblasts. Current Biology, 9, 505-511.
81. Ponniah, S., Wang, D. Z., Lim, K. L., & Pallen, C. J. (1999). Targeted disruption of the tyrosine phosphatase PTPalpha leads to constitutive downregulation of the kinases Src and Fyn. Current Biology, 9, 535-538.
82. Zheng, X. M., & Shalloway, D. (2001). Two mechanisms activate PTPalpha during mitosis. EMBO Journal, 20, 6037-6049.
83. Tracy, S., van der Geer, P., & Hunter, T. (1995). The receptor-like protein-tyrosine phosphatase, RPTP alpha, is phosphorylated by protein kinase C on two serines close to the inner face of the plasma membrane. Journal of Biological Chemistry, 270, 10587-10594.
84. den Hertog, J., Pals, C. E., Peppelenbosch, M. P., Tertoolen, L. G., de Laat, S. W., & Kruijer, W. (1993). Receptor protein tyrosine phosphatase alpha activates pp60c-src and is involved in neuronal differentiation. EMBO Journal, 12, 3789-3798.
85. Bodrikov, V., Leshchyns'ka, I., Sytnyk, V., Overvoorde, J., den Hertog, J., & Schachner, M. (2005). RPTPalpha is essential for NCAM-mediated p59fyn activation and neurite elongation. Journal of Cell Biology, 168, 127-139.
86. von Wichert, G., Jiang, G., Kostic, A., De Vos, K., Sap, J., & Sheetz, M. P. (2003). RPTP-alpha acts as a transducer of mechanical force on alphav/beta3-integrin-cytoskeleton linkages. Journal of Cell Biology, 161, 143-153.
87. Zeng, L., Si, X., Yu, W. P., Le, H. T., Ng, K. P., Teng, R. M., et al. (2003). PTP alpha regulates integrin-stimulated FAK autophosphorylation and cytoskeletal rearrangement in cell spreading and migration. Journal of Cell Biology, 160, 137-146.
88. Harder, K. W., Moller, N. P., Peacock, J. W., & Jirik, F. R. (1998). Protein-tyrosine phosphatase alpha regulates Src family kinases and alters cell-substratum adhesion. Journal of Biological Chemistry, 273, 31890-31900.
89. Pallen, C. J. (2003). Protein tyrosine phosphatase alpha (PTPalpha): A Src family kinase activator and mediator of multiple biological effects. Current Topics in Medicinal Chemstry, 3, 821-835.
90. Maksumova, L., Le, H. T., Muratkhodjaev, F., Davidson, D., Veillette, A., & Pallen, C. J. (2005). Protein tyrosine phosphatase alpha regulates Fyn activity and Cbp/PAG phosphorylation in thymocyte lipid rafts. Journal of Immunology, 175, 7947-7956.
91. Pera, I. L., Iuliano, R., Florio, T., Susini, C., Trapasso, F., Santoro, M., et al. (2005). The rat tyrosine phosphatase eta increases cell adhesion by activating c-Src through dephosphorylation of its inhibitory phosphotyrosine residue. Oncogene, 24, 3187-3195.
92. Roskoski Jr., R. (2005). Src kinase regulation by phosphorylation and dephosphorylation. Biochemical and Biophysical Research Communications, 331, 1-14.
93. Lau, K. H., Wu, L. W., Sheng, M. H., Amoui, M., Suhr, S. M., & Baylink, D. J. (2006). An osteoclastic protein-tyrosine phosphatase is a potential positive regulator of the c-Src protein-tyrosine kinase activity: a mediator of osteoclast activity. Journal of Cellular Biochemistry, 97, 940-955.
94. Ardini, E., Agresti, R., Tagliabue, E., Greco, M., Aiello, P., Yang, L. T., et al. (2000). Expression of protein tyrosine phosphatase alpha (RPTPalpha) in human breast cancer correlates with low tumor grade, and inhibits tumor cell growth in vitro and in vivo. Oncogene, 19, 4979-4987.
95. Bentires-Alj, M., & Neel, B. G. (2007). Protein-tyrosine phosphatase 1B is required for HER2/Neu-induced breast cancer. Cancer Research, 67, 2420-2424.
96. Julien, S. G., Dube, N., Read, M., Penney, J., Paquet, M., Han, Y., et al. (2007). Protein tyrosine phosphatase 1B deficiency or inhibition delays ErbB2-induced mammary tumorigenesis and protects from lung metastasis. Nature Genetics, 39, 338-346.
97. Bjorge, J. D., Pang, A., & Fujita, D. J. (2000). Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines. Journal of Biological Chemistry, 275, 41439-41446.
98. Bentires-Alj, M., Gil, S. G., Chan, R., Wang, Z. C., Wang, Y., Imanaka, N., et al. (2006). A role for the scaffolding adapter GAB2 in breast cancer. Nature Medicine, 12, 114-121.
99. Brummer, T., Schramek, D., Hayes, V. M., Bennett, H. L., Caldon, C. E., Musgrove, E. A., et al. (2006). Increased proliferation and altered growth factor dependence of human mammary epithelial cells overexpressing the Gab2 docking protein. Journal of Biological Chemistry, 281, 626-637.
100. Meng, S., Chen, Z., Munoz-Antonia, T., & Wu, J. (2005). Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor. Biochemical Journal, 391, 143-151.
101. Ke, Y., Lesperance, J., Zhang, E. E., Bard-Chapeau, E. A., Oshima, R. G., Muller, W. J., et al. (2006). Conditional deletion of Shp2 in the mammary gland leads to impaired lobulo-alveolar outgrowth and attenuated Stat5 activation. Journal of Biological Chemistry, 281, 34374-34380.
102. Mohi, M. G., & Neel, B. G. (2007). The role of Shp2 (PTPN11) in cancer. Current Opinion in Genetics & Development, 17, 23-30.
103. Chan, R. J., & Feng, G. S. (2007). PTPN11 is the first identified proto-oncogene that encodes a tyrosine phosphatase. Blood, 109, 862-867.
104. Kim, H., Chan, R., Dankort, D. L., Zuo, D., Najoukas, M., Park, M., et al. (2005). The c-Src tyrosine kinase associates with the catalytic domain of ErbB-2: implications for ErbB-2 mediated signaling and transformation. Oncogene, 24, 7599-7607.
105. Muthuswamy, S. K., & Muller, W. J. (1995). Direct and specific interaction of c-Src with Neu is involved in signaling by the epidermal growth factor receptor. Oncogene, 11, 271-279.
106. Muthuswamy, S. K., Siegel, P. M., Dankort, D. L., Webster, M. A., & Muller, W. J. (1994). Mammary tumors expressing the neu proto-oncogene possess elevated c-Src tyrosine kinase activity. Molecular and Cellular Biology, 14, 735-743.